文献速递炎症性肠病

系统综述与Meta分析:全结肠切除联合永久性回肠造口术后克罗恩病复发

Systematic review with meta-analysis: recurrence of Crohn's disease after total colectomy with permanent ileostomy.
PubMed 文献 · Aliment Pharmacol Ther · 2016-12-08

该系统综述与Meta分析纳入18项队列研究共1438例因结肠克罗恩病行全结肠切除联合永久性回肠造口术的成人患者,中位随访7.4年。临床复发风险为28.0%(95%CI 21.7-35.3),手术复发风险为16.0%(95%CI 11.1-22.7);有回肠病变史者复发风险为无回肠病变者的3.2倍(RR 3.2,95%CI 1.8-5.6)。

要点

  • 全结肠切除联合永久性回肠造口术后临床复发风险28.0%(95%CI 21.7-35.3)。
  • 手术复发风险16.0%(95%CI 11.1-22.7)。
  • 有回肠病变史者复发风险为无回肠病变者的3.2倍(RR 3.2,95%CI 1.8-5.6)。

核心结论

  • 全结肠切除联合永久性回肠造口术后约28%的结肠克罗恩病患者发生小肠临床复发。
  • 有回肠病变史者复发风险为无回肠病变者的3.2倍,作者认为该人群继续药物治疗可能是可取的。
  • 手术时无回肠炎症者,作者认为继续内镜监测可能识别无症状复发以指导治疗。

研究设计与样本

  • 系统综述与Meta分析,检索截至2016年3月31日,纳入18项队列研究共1438例因结肠克罗恩病行全结肠切除联合永久性回肠造口术的成人患者。
  • 中位随访7.4年(四分位距5.3-9.0年)。
  • 估计临床复发和手术复发的合并率(95%CI)及疾病复发危险因素。

主要发现

  • 临床复发风险28.0%(95%CI 21.7-35.3;14项研究,260/1004例患者),5年和10年中位累积复发率分别为23.5%(范围7-35)和40%(范围11-60)。
  • 手术复发风险16.0%(95%CI 11.1-22.7;10项研究,183/1092例患者),5年和10年中位累积复发率分别为10%(范围3-29)和18.5%(范围14-34)。
  • 基线无回肠病变者临床复发风险11.5%(95%CI 7.7-16.8),手术复发风险10.4%(95%CI 4.5-22.5)。
  • 有回肠病变史与疾病复发风险升高相关(RR 3.2;95%CI 1.8-5.6)。
  • 其他不一致的疾病复发危险因素为穿透性疾病和发病年龄年轻。

关键数值与推荐

  • 临床复发合并风险28.0%(95%CI 21.7-35.3)。
  • 手术复发合并风险16.0%(95%CI 11.1-22.7)。
  • 有回肠病变史者复发风险RR 3.2(95%CI 1.8-5.6)。

临床怎么用

  • 有回肠病变史者,作者认为继续药物治疗可能是可取的。
  • 手术时无回肠炎症者,作者认为继续内镜监测可能识别无症状复发以指导治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Subtotal or total colectomy or proctocolectomy with permanent ileostomy (TC-PI) may be a treatment option for medically refractory colonic Crohn's disease (CD). AIM: To perform a systematic review and meta-analysis to evaluate the rate, risk factors and outcomes of CD recurrence after TC-PI. METHODS: In a systematic review ending 31 March 2016, we identified 18 cohort studies (1438 adults) who underwent TC-PI for colonic CD (median follow-up, 7.4 years; interquartile range, 5.3-9.0). We estimated pooled rates [with 95% confidence interval (CI)] of clinical and surgical recurrence, and risk factors for disease recurrence. RESULTS: On meta-analysis, the risk of clinical recurrence after TC-PI was 28.0% (95% CI, 21.7-35.3; 14 studies, 260/1004 patients), with a 5 and 10-year median cumulative rate of 23.5% (range, 7-35) and 40% (range, 11-60) respectively. The risk of surgical recurrence was 16.0% (95% CI, 11.1-22.7; 10 studies; 183/1092 patients), with a 5 and 10-year median cumulative rate of 10% (range, 3-29) and 18.5% (range, 14-34) respectively. The risk of clinical and surgical recurrence in patients without ileal disease at baseline was 11.5% (95% CI, 7.7-16.8) and 10.4% (95% CI, 4.5-22.5) respectively. History of ileal disease was associated with 3.2 times higher risk of disease recurrence (RR, 3.2; 95% CI, 1.8-5.6). Other inconsistent risk factors for disease recurrence were penetrating disease and young age at disease onset. CONCLUSIONS: Small bowel clinical recurrence occurs in about 28% of patients after total colectomy with permanent ileostomy for colonic Crohn's disease. Disease recurrence risk is 3.2 times higher in patients with history of ileal disease, and continued medical therapy may be advisable in this population. In patients without ileal inflammation at surgery, continued endoscopic surveillance may identify asymptomatic disease recurrence to guide therapy.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Fumery M, Dulai PS, Meirick P, et al. Systematic review with meta-analysis: recurrence of Crohn's disease after total colectomy with permanent ileostomy. Aliment Pharmacol Ther. 2016. PMID: 27928830. doi:10.1111/apt.13886

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。